For: | Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J. Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact. World J Gastroenterol 2021; 27(17): 2039-2053 [PMID: 34007138 DOI: 10.3748/wjg.v27.i17.2039] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/2039.htm |
Number | Citing Articles |
1 |
Amit Kumar Dutta, Hemanth Chinthala, John Titus George, David Mathew Thomas, Anjilivelil Joseph Joseph. Anemia in inflammatory bowel disease—A comprehensive review. Indian Journal of Gastroenterology 2025; doi: 10.1007/s12664-024-01735-7
|
2 |
Aparna Malireddi, Mahlet Abera, Suchith B Suresh, Mehwish Ansar, Sruthi Boddeti, Khutaija Noor, Safeera Khan. Safety and Efficacy of Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.76065
|
3 |
Alexander Kaserer, Julia Braun, Alexander Mair, Samira Akbas, Julian Rössler, Heike A. Bischoff-Ferrari, Matthias Turina, Pierre-Alain Clavien, Isabelle Opitz, Andreas Hülsmeier, Gergely Karsai, Greta Gasciauskaite, Gabriela H. Spahn, Martin Schläpfer, Donat R. Spahn. Ferric carboxymaltose with or without phosphate substitution in iron deficiency or iron deficiency anemia before elective surgery – The DeFICIT trial. Journal of Clinical Anesthesia 2025; 101: 111727 doi: 10.1016/j.jclinane.2024.111727
|
4 |
TE Detlie, LN Karlsen, E Jørgensen, N Nanu, RF Pollock. Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway. Journal of Medical Economics 2024; : 1 doi: 10.1080/13696998.2024.2444833
|
5 |
Edyta Tulewicz-Marti, Paulina Szwarc, Martyna Więcek, Konrad Lewandowski, Tomasz Korcz, Malgorzata Cicha, G. Rydzewska. Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease—Results of a Prospective Single-Centre Study. Journal of Personalized Medicine 2023; 13(3): 458 doi: 10.3390/jpm13030458
|